RSS05-2011 (May 2011)

In-vivo Effectiveness of Adapalene 0.1%/ Benzoyl Peroxide 2.5% Gel on Antibiotic-sensitive and Resistant Propionibacterium acnes

| May 17, 2011 | 0 Comments

by James J. Leyden, MD, Department of Dermatology, University of Pennsylvania, Philadelphia, and the Skin Study Center, KGL, Inc., Broomall, Pennsylvania; Norman Preston, PhD; Galderma Laboratories, L.P., Fort Worth, Texas; Cris Osborn, PhD; Galderma Laboratories, L.P.; Ronald W. Gottschalk, MD, Galderma Laboratories, L.P. Disclosure: Dr. Leyden is a consultant for Galderma Laboratories, L.P. Drs. Preston, [...]

Continue Reading

One Laser for a Cosmetic/Dermatologic Practice

| May 17, 2011 | 0 Comments

Message from the Section Editor As the Section Editor of the “Aesthetic Update” section of The Journal of Clinical and Aesthetic Dermatology (JCAD), it is my extreme privilege to introduce a new series of guest submissions. We have invited some of the leading experts in aesthetic dermatology to contribute to the Aesthtic Update in 2011, [...]

Continue Reading

Microsphere Technology: Hype or Help?

| May 17, 2011 | 0 Comments

Leon H. Kircik, MD, Indiana University School of Medicine, Indianapolis, Indiana; Mount Sinai Medical Center, New York, New York; DermResearch, PLLC, Louisville, Kentucky

Continue Reading

Adult Seborrheic Dermatitis: A Status Report on Practical Topical Management

| May 17, 2011 | 0 Comments

James Q. Del Rosso, DO, Dermatology Residency Program Director, Valley Hospital Medical Center, Las Vegas, Nevada Disclosure: Dr. Del Rosso is a consultant, speaker, and/or researcher for Allergan, Coria, Galderma, Graceway, Intendis, Leo Pharma, Medicis, Onset Therapeutics, Ortho Dermatology, PharmaDerm, Promius, Quinnova, Ranbaxy, SkinMedica, Stiefel, Triax, Unilever, and Warner Chilcott.

Continue Reading

Treatment of Basal Cell Carcinoma with Curettage Followed by Imiquimod 3.75% Cream

| May 17, 2011 | 0 Comments

Joshua A. Zeichner, MD; Rita V. Patel, MD; Miriam B. Birge, MD, both from Mount Sinai Medical Center, New York, New York Disclosure: The authors report no relevant conflicts of interest. Abstract Basal cell carcinoma is the most common form of nonmelanoma skin cancer in the United States. Treatment modalities include both surgical, medical, or [...]

Continue Reading

Filler Cheeks: A Bright Idea? The “Eyes” Have It

| May 17, 2011 | 0 Comments

Richard G. Fried, MD, PhD Dr. Fried is in private practice, Yardley Dermatology Associates, Yardley, Pennsylvania. Disclosure: Dr. Fried is a consultant or speaker for Allergan and Bioform Medical.

Continue Reading